Tag: clinical trials
Breaking News
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
Strasbourg (France), Tokyo (Japan) and Waltham, Mass, Mar 5, 2024 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and...
Gene Silencing Slashes Cholesterol in Mice—No Gene Edits Required
With just one shot, scientists have slashed cholesterol levels in mice. The treatment lasted for at least half their lives.The shot may sound like...
Quality assurance: new approaches for ultrahigh-dose rate FLASH radiotherapy – Physics World
Join the audience for a live webinar at 3 p.m. BST/10 a.m. EDT on 10 April 2024 exploring QA for ultrahigh-dose rate FLASH radiotherapy
Want...
LYC Healthcare Reports Strong Q3 FY2024 Results of RM36.0 Million
KUALA LUMPUR, Feb 28, 2024 - (ACN Newswire) - LYC Healthcare Berhad (“LYC Healthcare” or the “Group”), a leading provider of comprehensive healthcare and...
Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology
The French startup has launched with a seed funding of $35M, led by Sofinnova Partners, with Bpifrance Large Venture, and additional funding from top...
Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report
Clinical development productivity rose in 2023, primarily due to an improvement in the composite success rate, a function of phases successfully completed in the...
CIBC Innovation Banking Provides Growth Capital to InsightRX
SAN FRANCISCO–(BUSINESS WIRE)–CIBC Innovation Banking announced today that it has provided growth financing to InsightRX, a San Francisco-based software company leveraging quantitative pharmacology and...
Self-propelling nanobots shrink bladder tumours in mice by 90% – Physics World
<a href="https://coingenius.news/wp-content/uploads/2024/02/self-propelling-nanobots-shrink-bladder-tumours-in-mice-by-90-physics-world-2.jpg" data-fancybox data-src="https://coingenius.news/wp-content/uploads/2024/02/self-propelling-nanobots-shrink-bladder-tumours-in-mice-by-90-physics-world-2.jpg" data-caption="Targeted treatment Accumulation of nanobots in the tumour visualized by microscopy. (Courtesy: IRB Barcelona)">
Imagine an army of self-propelling, radioisotope-covered particles...
IGC Pharma Reports Third Quarter Fiscal 2024 Results
POTOMAC, Md.–(BUSINESS WIRE)–#AD–IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the third fiscal quarter of 2024...
Karlsgate Revolutionizes Data Collaboration with New Remote Integration Capabilities
Unveiling a Groundbreaking Solution, Karlsgate Introduces a Full-Stack Approach to Privacy Protection
NEW YORK–(BUSINESS WIRE)–#data–Karlsgate is thrilled to announce the launch of KIE Integration, a...
Cosmic code of conduct: the ethics of human testing in space – Physics World
Biomedical ethicist Vasiliki Rahimzadeh speaks to Tami Freeman about why the rapid growth of the commercial space sector makes it imperative that we develop...
Metal-free graphene quantum dots show potential for cancer treatment – Physics World
<a href="https://coingenius.news/wp-content/uploads/2024/02/metal-free-graphene-quantum-dots-show-potential-for-cancer-treatment-physics-world-2.jpg" data-fancybox data-src="https://coingenius.news/wp-content/uploads/2024/02/metal-free-graphene-quantum-dots-show-potential-for-cancer-treatment-physics-world-2.jpg" data-caption="Chemodynamic therapy Schematic illustration showing the role of graphene quantum dots, derived from red blood cell membranes, as nanozymes for...
Latest Intelligence
